Published in Virchows Arch on January 01, 1995
Vascular endothelial growth factor in eye disease. Prog Retin Eye Res (2008) 2.73
Expression of vascular endothelial growth factor in experimental choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol (1997) 1.65
Role of vascular permeability factor/vascular endothelial growth factor in eye disease. Br J Ophthalmol (1997) 1.29
Involvement of Müller glial cells in epiretinal membrane formation. Graefes Arch Clin Exp Ophthalmol (2009) 1.05
Localisation of vascular endothelial growth factor and its receptors to cells of vascular and avascular epiretinal membranes. Br J Ophthalmol (1997) 1.04
Inflammatory mechanisms of idiopathic epiretinal membrane formation. Mediators Inflamm (2013) 0.99
The effect of vascular endothelial growth factor in the progression of bladder cancer and diabetic retinopathy. Int J Clin Exp Med (2013) 0.94
Antiangiogenic properties of fasudil, a potent Rho-Kinase inhibitor. Jpn J Ophthalmol (2008) 0.93
Fibrinogen stimulates in vitro angiogenesis by choroidal endothelial cells via autocrine VEGF. Graefes Arch Clin Exp Ophthalmol (2004) 0.85
Suppression of experimental choroidal neovascularization utilizing KDR selective receptor tyrosine kinase inhibitor. Graefes Arch Clin Exp Ophthalmol (2003) 0.84
Antiangiogenic mechanisms of simvastatin in retinal endothelial cells. Graefes Arch Clin Exp Ophthalmol (2010) 0.80
Current Trends about Inner Limiting Membrane Peeling in Surgery for Epiretinal Membranes. J Ophthalmol (2015) 0.80
Emerging roles for antiangiogenesis factors in management of ocular disease. Clin Ophthalmol (2013) 0.80
Triamcinolone acetonide suppresses interleukin-1 beta-mediated increase in vascular endothelial growth factor expression in cultured rat Müller cells. Graefes Arch Clin Exp Ophthalmol (2005) 0.77
Gene Expression Analysis of the Irrigation Solution Samples Collected during Vitrectomy for Idiopathic Epiretinal Membrane. PLoS One (2016) 0.75
CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science (1997) 13.67
The complete sequence of the rice (Oryza sativa) chloroplast genome: intermolecular recombination between distinct tRNA genes accounts for a major plastid DNA inversion during the evolution of the cereals. Mol Gen Genet (1989) 9.53
The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science (1992) 7.49
Total synthesis of taxol. Nature (1994) 3.22
Feedback inhibition of specifically sensitized lymphocytes. J Exp Med (1974) 3.11
Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis. Mol Cell Biol (1997) 3.02
Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol (1995) 2.95
cAMP-GEFII is a direct target of cAMP in regulated exocytosis. Nat Cell Biol (2000) 2.83
VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells. Oncogene (1999) 2.66
Effects of pulse methylprednisolone on bone and marrow tissues: corticosteroid-induced osteonecrosis in rabbits. Arthritis Rheum (1997) 2.42
Takayasu's arteritis. Lancet (2000) 2.34
NK1.1+ CD4+ CD8- thymocytes with specific lymphokine secretion. Eur J Immunol (1993) 2.32
The modifying effect of BCG on the immunological induction of T cells. J Exp Med (1974) 2.30
Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patients. Br J Cancer (2008) 2.21
Quality of life and disease-related symptoms in previously treated Japanese patients with non-small-cell lung cancer: results of a randomized phase III study (V-15-32) of gefitinib versus docetaxel. Ann Oncol (2009) 2.14
Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. J Clin Invest (1999) 2.09
Subpleural mononuclear cell infiltration. Significance in the differential diagnosis of pleuritis showing nonspecific histologic findings. Chest (1990) 2.07
Moyamoya disease. Neuropathology (2000) 2.06
Blockade of type beta transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat. Proc Natl Acad Sci U S A (1999) 1.95
Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res (2001) 1.91
Radiofrequency ablation and percutaneous ethanol injection in patients with small hepatocellular carcinoma: a comparative study. Jpn J Clin Oncol (2001) 1.81
Effects of CYP2C19 genotypic differences in the metabolism of omeprazole and rabeprazole on intragastric pH. Aliment Pharmacol Ther (2001) 1.77
Requirements for localization of p130cas to focal adhesions. Mol Cell Biol (1997) 1.76
Prognostic factors of vision in patients with Behçet disease. Ophthalmology (1995) 1.75
Exercise-induced U-wave alterations as a marker of well-developed and well-functioning collateral vessels in patients with effort angina. J Am Coll Cardiol (2000) 1.73
Expression, function, and clinical implications of the estrogen receptor beta in human lung cancers. Biochem Biophys Res Commun (2001) 1.67
Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin. Br J Cancer (2004) 1.67
An ultrastructural study of subacute necrotizing lymphadenitis. Am J Pathol (1982) 1.66
The crystal structure of calcium-free human m-calpain suggests an electrostatic switch mechanism for activation by calcium. Proc Natl Acad Sci U S A (2000) 1.65
Inhibition of transforming growth factor beta prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats. Hepatology (2000) 1.65
Expression of vascular endothelial growth factor in experimental choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol (1997) 1.65
Resection of hepatic and pulmonary metastases in patients with colorectal carcinoma. Cancer (1998) 1.62
Vascular endothelial growth factor secreted by replicating hepatocytes induces sinusoidal endothelial cell proliferation during regeneration after partial hepatectomy in rats. J Hepatol (2001) 1.62
Treatment strategy for small hepatocellular carcinoma: comparison of long-term results after percutaneous ethanol injection therapy and surgical resection. Hepatology (2001) 1.61
Cholesterol granuloma in the petrous apex: case report and review. Acta Neurochir (Wien) (2001) 1.61
Antibody removal therapy used successfully at delivery of a pregnant patient with Glanzmann's thrombasthenia and multiple anti-platelet antibodies. Vox Sang (1991) 1.60
A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. The Japanese Pediatric IgA Nephropathy Treatment Study Group. J Am Soc Nephrol (1999) 1.60
Capillary blood flow velocity measurements in cystoid macular edema with the scanning laser ophthalmoscope. Am J Ophthalmol (1994) 1.60
Effective hepatic artery chemoembolization for advanced hepatocellular carcinoma with extensive tumour thrombus through the hepatic vein. J Gastroenterol Hepatol (1999) 1.59
Effects of intravitreal administration of steroids on experimental subretinal neovascularization in the subhuman primate. Arch Ophthalmol (1985) 1.58
Optimal margins and lymphadenectomy in colonic cancer surgery. Br J Surg (2011) 1.58
Correlation between metastatic site, histological type, and serum tumor markers of gastric carcinoma. Hum Pathol (1995) 1.57
Bartonella spp. isolated from wild and domestic ruminants in North America. Emerg Infect Dis (2000) 1.56
Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival rates. AJR Am J Roentgenol (2001) 1.54
Benefits and limits of hepatic resection for gastric metastases. Am J Surg (2001) 1.52
All-trans and 9-cis retinoic acid enhance 1,25-dihydroxyvitamin D3-induced monocytic differentiation of U937 cells. Leuk Res (1996) 1.50
Subretinal neovascularization in the rat induced by IRBP synthetic peptides. Exp Eye Res (1994) 1.48
Antineutrophil cytoplasmic antibodies in Japanese patients with inflammatory bowel disease: prevalence and recognition of putative antigens. Am J Gastroenterol (1999) 1.48
Effect of re-treatment with gefitinib ('Iressa', ZD1839) after acquisition of resistance. Ann Oncol (2004) 1.48
The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas. Lab Invest (1996) 1.48
Aggressive surgical approaches to hilar cholangiocarcinoma: hepatic or local resection? Surgery (1998) 1.47
Hepatic resection for colorectal metastases: analysis of prognostic factors. Dis Colon Rectum (1999) 1.46
Gastroesophageal reflux after distal gastrectomy: possible significance of the angle of His. Am J Gastroenterol (1998) 1.46
Local adenovirus-mediated transfer of C-type natriuretic peptide suppresses vascular remodeling in porcine coronary arteries in vivo. J Am Coll Cardiol (2000) 1.44
Aggressive surgical resection for hepatic metastases involving the inferior vena cava. Am J Surg (1999) 1.44
Aqueous humor pathways through the trabecular meshwork and into Schlemm's canal in the cynomolgus monkey (Macaca irus). An electron microscopic study. Am J Ophthalmol (1972) 1.44
Vascular endothelial growth factor plays a role in hyperpermeability of diabetic retinal vessels. Ophthalmic Res (1995) 1.44
Fecal eosinophil granule-derived proteins reflect disease activity in inflammatory bowel disease. Am J Gastroenterol (1999) 1.43
Pharmacokinetics of cefpiramide (SM-1652) in humans. Antimicrob Agents Chemother (1984) 1.43
Immunofluorescent studies of fibronectin and laminin in the human eye. Invest Ophthalmol Vis Sci (1987) 1.43
Structure of the human glucokinase gene and identification of a missense mutation in a Japanese patient with early-onset non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab (1992) 1.42
Prevalence of age related maculopathy in a representative Japanese population: the Hisayama study. Br J Ophthalmol (2001) 1.41
Allelotype of non-small cell lung carcinoma--comparison between loss of heterozygosity in squamous cell carcinoma and adenocarcinoma. Cancer Res (1992) 1.41
Dominant negative forms of Akt (protein kinase B) and atypical protein kinase Clambda do not prevent insulin inhibition of phosphoenolpyruvate carboxykinase gene transcription. J Biol Chem (1999) 1.40
CPT-11: a new derivative of camptothecin for the treatment of refractory or relapsed small-cell lung cancer. J Clin Oncol (1992) 1.40
High-density lipoprotein particles are large in patients with variant angina. Cardiovasc Res (1998) 1.40
Augmented enhancement of in vitro production of inflammatory cytokines in peripheral blood mononuclear cells in patients undergoing simultaneous resection of the liver and gastrointestinal tract. Crit Care Med (1999) 1.39
Electron microscopic demonstration of dehydrogenase activity with a new osmiophilic ditetrazolium salt (TC-NBT). J Histochem Cytochem (1967) 1.39
Hypertrophic cardiomyopathy in patients with diabetes mellitus associated with mitochondrial tRNA(Leu)(UUR) gene mutation. Intern Med (1995) 1.39
Ocular histopathologic findings in a 46-year-old man with primary hyperoxaluria. Arch Ophthalmol (1991) 1.39
Intimal neovascularization in human coronary atherosclerosis: its origin and pathophysiological significance. Hum Pathol (1995) 1.39
A precise, three-dimensional atlas of myocardial perfusion correlated with coronary arteriographic anatomy. J Nucl Cardiol (2001) 1.38
EGFR mutation in gefitinib-responsive small-cell lung cancer. Ann Oncol (2005) 1.38
Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization. Invest Ophthalmol Vis Sci (2000) 1.37
Parenchyma-preserving hepatectomy in the surgical treatment of hilar cholangiocarcinoma. J Am Coll Surg (1999) 1.37
Comparison of diagnostic methods for diabetes mellitus based on prevalence of retinopathy in a Japanese population: the Hisayama Study. Diabetologia (2004) 1.36
Vascular anatomy of duodenal varices: angiographic and histopathological assessments. Am J Gastroenterol (1993) 1.36
Soluble E-cadherin fragments increased in circulation of cancer patients. Br J Cancer (1994) 1.36
Prevalence of intracranial saccular aneurysms in a Japanese community based on a consecutive autopsy series during a 30-year observation period. The Hisayama study. Stroke (1999) 1.34
A phase I and pharmacokinetic study of NK105, a paclitaxel-incorporating micellar nanoparticle formulation. Br J Cancer (2007) 1.34
Purification and partial characterization of linoleoyl-CoA desaturase from rat liver microsomes. Arch Biochem Biophys (1981) 1.34
Pathogenesis of drusen in the primate. Invest Ophthalmol Vis Sci (1986) 1.33
Dendritic cells and immunity against cancer. J Intern Med (2011) 1.32
Three new regions on chromosome 17p13.3 distal to p53 with possible tumor suppressor gene involvement in lung cancer. Jpn J Cancer Res (2000) 1.32
Thymidylate synthase as a determinant of pemetrexed sensitivity in non-small cell lung cancer. Br J Cancer (2011) 1.32
Nonsurgical management of ruptured pseudoaneurysm in patients with hepatobiliary pancreatic diseases. Am J Gastroenterol (2001) 1.32
Possible contribution of hyalocytes to idiopathic epiretinal membrane formation and its contraction. Br J Ophthalmol (2009) 1.31
Identification of DBC1 as a transcriptional repressor for BRCA1. Br J Cancer (2010) 1.31
A noninvasive measurement of reactive hyperemia that can be used to assess resistance artery endothelial function in humans. Am J Cardiol (2001) 1.31
Stretch-induced collagen synthesis in cultured smooth muscle cells from rabbit aortic media and a possible involvement of angiotensin II and transforming growth factor-beta. J Vasc Res (1998) 1.30